A meta-analysis concluded that the combination of a-LA and valsartan significantly lowered urinary albumin levels and oxidative stress, boosted antioxidant capacity, and mitigated renal function damage in patients with diabetic nephropathy [258]. The gene discussed is ALB; the disease is diabetic kidney disease.